Fingerprint
Dive into the research topics of 'Phase II study of gemcitabine, carboplatin, and iniparib as neoadjuvant therapy for triple-negative and BRCA1/2 mutation-associated breast cancer with assessment of a tumor-based measure of genomic instability: PrECOG 0105'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically